Loading organizations...

§ Private Profile · 62 Maritime Dr, Mystic, Connecticut, 06355, United States
R&D company developing novel crop protection products for farmers, using AI and machine learning via its Enkompass™ platform.
Enko Chem is a Mystic, Connecticut-based agricultural technology company that discovers and develops novel crop protection products by applying advanced pharmaceutical drug discovery techniques. The business utilizes its proprietary Enkompass platform, which integrates artificial intelligence, machine learning, and DNA-encoded libraries, to create targeted chemical solutions for weeds, pests, and crop diseases. As of 2020, the enterprise had raised $66 million in total venture funding to advance its research collaborations and commercialization pipeline. Enko Chem is backed by a syndicate of prominent institutional investors, including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, and Novalis LifeSciences. Recently ranked forty-fifth on TIME Magazine's America's Top GreenTech Companies list, the firm appointed Tony Klemm as chief executive officer in March 2025. The organization was originally incubated and founded in 2017 by former chief executive Jacqueline Heard.
Enko Chem has raised $195.0M across 3 funding rounds.
Enko Chem has raised $195.0M in total across 3 funding rounds.
Enko Chem is an AI-informed agricultural life sciences company that develops novel, safe, and sustainable crop protection products using its proprietary ENKOMPASS™ platform, which combines DNA-encoded libraries (DEL), artificial intelligence (AI), machine learning, and structure-based design to discover targeted solutions against pests, weeds, and diseases.[1][2][3][4] It serves farmers worldwide, particularly addressing challenges like pest resistance—where 40% of crops are lost annually—and climate-driven threats, by creating potent, selective molecules faster and at lower cost than traditional methods, with potential for billions in sales across 50 programs and a first product launch by decade's end.[1][2] Backed by partners like the Gates Foundation (Series B, 2020) and collaborators such as Syngenta, Enko accelerates innovation for smallholder farmers in Sub-Saharan Africa and South Asia while scaling to global markets.[6][8]
Enko Chem emerged from the vision of applying pharmaceutical drug discovery techniques—like DEL and AI—to agriculture, led by Jacqueline Heard, CEO and co-founder, a proven scientist tackling crop threats, alongside Tom Meade, Chief Science Officer, who drives the target-based platform integrating DNA, chemistry, and machine learning.[2][7] The company, headquartered in Mystic, Connecticut, with research facilities, was founded to address stagnant innovation in crop protection, where decades-old products fail due to resistance; a pivotal moment came in September 2024 when ENKOMPASS™ identified a novel weed control mode of action (MOA) and inhibitors in just four months.[2] Early traction includes Gates Foundation investment in 2020 for affordable solutions in developing regions and partnerships like Syngenta for AI-driven weed control molecules, building on proprietary datasets from billions of binding observations.[6][8]
Enko rides the agri-tech convergence of AI, biotech, and pharma tools, adapting DEL (first in ag from pharma) to combat rising pest resistance, climate impacts, and food security needs for a growing global population.[1][2][3][5] Timing is critical amid crop losses (40% to pests) and regulatory pressures for sustainable alternatives, where Enko's platform outpaces legacy methods by unlocking novel MOAs and vast chemical spaces.[2][7] Market forces like partnerships (Syngenta, Gates) amplify reach, influencing the ecosystem by accelerating R&D—e.g., AI for weed control—and enabling affordable tools for smallholders, potentially disrupting a stagnant industry toward precision, eco-friendly crop health.[6][8]
Enko is poised to launch its first transformative product by 2030, scaling 50 programs with partners to deliver billions in revenue through safer herbicides, insecticides, and yield enhancers.[1] Trends like AI-driven drug/ag discovery, climate-resilient farming, and resistance management will propel growth, evolving Enko's influence from pioneer platform to ecosystem leader supplying novel MOAs globally. This positions Enko Chem as the force changing how the world grows food—faster, safer, and sustainably.
Enko Chem has raised $195.0M across 3 funding rounds. Most recently, it raised $80.0M Enko Chem, Inc. - Series C in January 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 31, 2023 | $80M Series C | Akroyd, Prem Pavoor, Endeavor8, Nufarm | — | Announced |
| Jul 27, 2022 | $70M Series C | Greg Hunt | Tahir Gozel, Alumni Ventures, Anterra Capital, Bill & Melinda Gates Foundation, Eight Roads Ventures, Endeavor8, Finistere Ventures, Germin8 Ventures, Novalis LifeSciences, Rabo Food & Agri Innovation Fund, TO Ventures Food | Announced |
| Jun 26, 2020 | $45M Series B | Vipula Shukla | — | Announced |
Enko Chem has raised $195.0M in total across 3 funding rounds.
Enko Chem's investors include Akroyd, Prem Pavoor, Endeavor8, Nufarm, Greg Hunt, Tahir Gozel, Alumni Ventures, Anterra Capital, Bill & Melinda Gates Foundation, Eight Roads Ventures, Finistere Ventures, Germin8 Ventures.